CIK: 0001782539
Total reported value
$121.3M
Reporting period: 2026-03-31 · Number of holdings: 24
Nan Fung Group Holdings Ltd disclosed 24 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $121.3M and a quarterly turnover rate of 35.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "N"
Nan Fung Group Holdings Ltd's disclosed holdings carry a Herfindahl concentration index of 0.133 — mathematically equivalent to about 8 equally-sized positions, well below its 24 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.51), with a handful of outsized bets alongside many smaller positions.
Recent activity leans toward adding more aggressively to already-large existing positions than to newly initiated ones (a 4.2 percentage-point tilt) — a pattern consistent with a momentum-following approach.
Sector classification currently covers about 17% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add LBRX
+110.2% $8.9M
Add EVMN
0.0% $8.5M
Trim MDGL
-52.2% -$3.9M
Trim HELP
0.0% -$1.6M
Trim OCS
-31.9% -$952.3K
Trim RYTM
0.0% -$985.8K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | EVMN | Evommune INC | Stock-Other | 27.32% | +5.24% | — | |
| 2 | MPLT | Maplight Therapeutics INC | Stock-Other | 16.28% | +1.01% | — | |
| 3 | LBRX | Lb Pharmaceuticals INC | Stock-Other | 12.82% | +6.84% | +110.22% | |
| 4 | OCS | Oculis Holding AG | Stock-Other | 7.69% | -1.51% | -31.85% | |
| 5 | INCY | Incyte CORP | Stock-Healthcare | 4.17% | -1.05% | -8.95% | |
| 6 | ONC | Beone Medicines Ltd-adr | Stock-Other | 3.85% | -0.43% | — | |
| 7 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 3.52% | -1.19% | — | |
| 8 | CELC | Celcuity INC | Stock-Other | 2.66% | +2.66% | NEW | |
| 9 | ASND | Ascendis Pharma A/S | Stock-Other | 2.57% | -0.03% | — | |
| 10 | PCOR | Procore Technologies INC | Stock-Tech | 2.51% | -0.96% | — | |
| 11 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 2.45% | -3.74% | -52.22% | |
| 12 | KYMR | Kymera Therapeutics INC | Stock-Other | 2.12% | -0.03% | — | |
| 13 | ACAD | Acadia Pharmaceuticals INC | Stock-Healthcare | 1.89% | -0.57% | — | |
| 14 | HELP | Cybin INC | Stock-Other | 1.82% | -1.55% | — | |
| 15 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.69% | -0.42% | — | |
| 16 | RVMD | Revolution Medicines INC | Stock-Healthcare | 1.54% | +0.17% | — | |
| 17 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 1.51% | -0.67% | — | |
| 18 | INSM | Insmed INC | Stock-Healthcare | 0.89% | +0.89% | NEW | |
| 19 | ETHA | Ishares Ethereum Trust ETF | ETF-Other | 0.66% | -0.35% | — | |
| 20 | HRMY | Harmony Biosciences Holdings | Stock-Other | 0.62% | -0.29% | — | |
| 21 | TRDA | Entrada Therapeutics INC | Stock-Other | 0.51% | +0.06% | — | |
| 22 | IBIT | Ishares Bitcoin Trust ETF | ETF-Crypto | 0.51% | -0.20% | — | |
| 23 | RANI | Rani Therapeutics Holdings-a | Stock-Other | 0.30% | -0.30% | — | |
| 24 | BOLT | Bolt Biotherapeutics INC | Stock-Other | 0.10% | -0.19% | -49.87% |
Performance for Q3 2026
-4.5%
Performance Last 4 Quarters
+26.9%
Based on 87% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 24 | $121.3M | 35 | |
| 2025-12-31 | 27 | $111.7M | 76 | |
| 2025-09-30 | 24 | $59.6M | 100 | |
| 2025-06-30 | 20 | $63.4M | 0 | |
| 2025-03-31 | 35 | $122.6M | 100 | |
| 2024-12-31 | 35 | $116.9M | 0 | |
| 2024-09-30 | 38 | $116.1M | 0 | |
| 2024-06-30 | 44 | $93.7M | 0 | |
| 2024-03-31 | 45 | $107.9M | 0 | |
| 2023-12-31 | 39 | $160.6M | 0 | |
| 2023-09-30 | 39 | $123.5M | 0 | |
| 2023-06-30 | 43 | $156.5M | 0 | |
| 2023-03-31 | 44 | $147.0M | 0 | |
| 2022-12-31 | 42 | $145.1M | 0 | |
| 2022-09-30 | 39 | $156.7M | 0 | |
| 2022-06-30 | 41 | $145.6M | 0 | |
| 2022-03-31 | 45 | $210.9M | 0 | |
| 2021-12-31 | 55 | $338.0M | 0 | |
| 2021-09-30 | 28 | $312.4M | 0 | |
| 2021-06-30 | 24 | $321.8M | — |
Nan Fung Group Holdings Ltd's most significant position changes for 2026-03-31: New buy: Celcuity INC (CELC); Sold out: Standard Biotools INC (LAB); New buy: Insmed INC (INSM); Sold out: Replimune Group INC (REPL); Sold out: Bicycle Therapeutics Plc-adr (BCYC).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LBRX | Lb Pharmaceuticals INC | +6.8% | +110.22% | Add |
| 2 | EVMN | Evommune INC | +5.2% | — | Unchanged |
| 3 | MPLT | Maplight Therapeutics INC | +1% | — | Unchanged |
| 4 | RVMD | Revolution Medicines INC | +0.2% | — | Unchanged |
| 5 | TRDA | Entrada Therapeutics INC | +0.1% | — | Unchanged |
| 6 | ASND | Ascendis Pharma A/S | 0% | — | Unchanged |
| 7 | KYMR | Kymera Therapeutics INC | 0% | — | Unchanged |
| 8 | BOLT | Bolt Biotherapeutics INC | -0.2% | -49.87% | Trim |
| 9 | IBIT | Ishares Bitcoin Trust ETF | -0.2% | — | Unchanged |
| 10 | HRMY | Harmony Biosciences Holdings | -0.3% | — | Unchanged |
| 11 | RANI | Rani Therapeutics Holdings-a | -0.3% | — | Unchanged |
| 12 | ETHA | Ishares Ethereum Trust ETF | -0.4% | — | Unchanged |
| 13 | ARGX | Argenx Se - Adr | -0.4% | — | Unchanged |
| 14 | ONC | Beone Medicines Ltd-adr | -0.4% | — | Unchanged |
| 15 | ACAD | Acadia Pharmaceuticals INC | -0.6% | — | Unchanged |
| 16 | RXRX | Recursion Pharmaceuticals-a | -0.7% | — | Unchanged |
| 17 | PCOR | Procore Technologies INC | -1% | — | Unchanged |
| 18 | INCY | Incyte CORP | -1.1% | -8.95% | Trim |
| 19 | RYTM | Rhythm Pharmaceuticals INC | -1.2% | — | Unchanged |
| 20 | OCS | Oculis Holding AG | -1.5% | -31.85% | Trim |
| 21 | HELP | Cybin INC | -1.6% | — | Unchanged |
| 22 | MDGL | Madrigal Pharmaceuticals INC | -3.7% | -52.22% | Trim |
| 23 | CELC | Celcuity INC | — | NEW | New buy |
| 24 | LAB | Standard Biotools INC | — | EXIT | Sold out |
| 25 | INSM | Insmed INC | — | NEW | New buy |
| 26 | REPL | Replimune Group INC | — | EXIT | Sold out |
| 27 | BCYC | Bicycle Therapeutics Plc-adr | — | EXIT | Sold out |
| 28 | RKLB | Rocket Lab CORP | — | EXIT | Sold out |
| 29 | BSLK | Bolt Projects Holdings INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-13 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-13 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-14 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-13 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-13 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-13 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-14 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-13 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-13 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-11 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-12 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-13 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-10 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-12 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-09-22 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002056338
Total reported value
$121.3M
73 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002133972
Total reported value
$121.2M
29 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002047089
Total reported value
$121.3M
68 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001834239
Total reported value
$1.0B
5 stks
2026-03-31
2 of the top 5 holdings overlap, including Oculis Holding AG
CIK 0001844645
Total reported value
$279.8M
13 stks
2026-03-31
2 of the top 5 holdings overlap, including Oculis Holding AG
CIK 0001848809
Total reported value
$159.6M
50 stks
2026-03-31
2 of the top 5 holdings overlap, including Evommune INC